Literature DB >> 15455386

Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors.

Doudja Hammouda1, Nubia Muñoz, Rolando Herrero, Annie Arslan, Anissa Bouhadef, Malika Oublil, Belhout Djedeat, Bernard Fontanière, Peter Snijders, Chris Meijer, Silvia Franceschi.   

Abstract

We conducted a hospital-based case-control study in Algiers, Algeria. A total of 198 cervical carcinoma (CC) cases (including 15 adeno- and adenosquamous carcinomas) and 202 age-matched control women were included. Human papillomavirus (HPV) DNA in cervical cells was evaluated using a PCR assay. Odds ratios and corresponding confidence intervals were computed by means of unconditional multiple logistic regression models. HPV infection was detected in 97.7% of CC cases and 12.4% of control women (OR = 635). Nineteen different HPV types were found. HPV 16 was the most common type in both CC cases and control women, followed by HPV 18 and 45. Twelve types (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 66 and 73) were found as single infections in CC cases. Multiple HPV infections did not show a higher odds ratio for CC than single infections. In addition to HPV infection, husband's extramarital sexual relationships with other women (OR = 4.8) or prostitutes (OR = 3.2), residing in a rural environment for most of one's life (OR = 4.9) and indicators of poor sanitation or poor hygiene were the strongest risk factors for CC. Oral contraceptive use was unrelated to CC risk, while multiparity emerged as a significant risk factor after adjustment for sexual habits. Intrauterine device users showed a lower CC risk than nonusers. The role of major risk factors, except inside toilet, was confirmed in the analysis restricted to HPV-positive women. The distribution of HPV types in CC cases and control women in Algeria is more similar to the one found in Europe than the one in sub-Saharan Africa, where HPV 16 is less prevalent. A vaccine against HPV 16 and 18 may be effective in more than 3/4 of CCs in Algeria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15455386     DOI: 10.1002/ijc.20600

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Human papillomavirus 45 genetic variation and cervical cancer risk worldwide.

Authors:  Alyce A Chen; Daniëlle A M Heideman; Debby Boon; Tarik Gheit; Peter J F Snijders; Massimo Tommasino; Silvia Franceschi; Gary M Clifford
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

Review 2.  Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions.

Authors:  Ala-Eddin Al Moustafa; Rana Al-Awadhi; Nabiha Missaoui; Ishag Adam; Raika Durusoy; Lina Ghabreau; Nizar Akil; Hussain Gadelkarim Ahmed; Amber Yasmeen; Ghazi Alsbeih
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide.

Authors:  Alyce A Chen; Tarik Gheit; Silvia Franceschi; Massimo Tommasino; Gary M Clifford
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

4.  Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.

Authors:  Luisa Galati; Jean-Damien Combes; Florence Le Calvez-Kelm; Sandrine McKay-Chopin; Nathalie Forey; Mathis Ratel; James McKay; Tim Waterboer; Lea Schroeder; Gary Clifford; Massimo Tommasino; Tarik Gheit
Journal:  Microbiol Spectr       Date:  2022-02-28

5.  Socio-economic and cultural vulnerabilities to cervical cancer and challenges faced by patients attending care at Tikur Anbessa Hospital: a cross sectional and qualitative study.

Authors:  Sara Kebede Tadesse
Journal:  BMC Womens Health       Date:  2015-09-16       Impact factor: 2.809

6.  Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies.

Authors:  Erik Bernard; Margarita Pons-Salort; Michel Favre; Isabelle Heard; Elisabeth Delarocque-Astagneau; Didier Guillemot; Anne C M Thiébaut
Journal:  BMC Infect Dis       Date:  2013-08-13       Impact factor: 3.090

7.  Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Authors:  S Franceschi; M Plummer; G Clifford; S de Sanjose; X Bosch; R Herrero; N Muñoz; S Vaccarella
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

8.  Prevalence of HPV Infection and High Risk HPV Genotypes (16, 18), among Monogamous and Polygamous Women, In Zabol, Iran.

Authors:  I Shahramian; Z Heidari; Hr Mahmoudzadeh-Sagheb; A Moradi; F Forghani
Journal:  Iran J Public Health       Date:  2011-09-30       Impact factor: 1.429

9.  Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries.

Authors:  K S Louie; S de Sanjose; M Diaz; X Castellsagué; R Herrero; C J Meijer; K Shah; S Franceschi; N Muñoz; F X Bosch
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

10.  Human Papillomavirus type distribution in invasive cervical cancer in Uganda.

Authors:  Michael Odida; Silvia de Sanjosé; Wim Quint; Xavier F Bosch; Joellen Klaustermeier; Elisabete Weiderpass
Journal:  BMC Infect Dis       Date:  2008-06-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.